Anne S. De Groot

8.6k total citations
231 papers, 6.3k citations indexed

About

Anne S. De Groot is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anne S. De Groot has authored 231 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 103 papers in Immunology and 55 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anne S. De Groot's work include vaccines and immunoinformatics approaches (100 papers), Monoclonal and Polyclonal Antibodies Research (54 papers) and Immunotherapy and Immune Responses (47 papers). Anne S. De Groot is often cited by papers focused on vaccines and immunoinformatics approaches (100 papers), Monoclonal and Polyclonal Antibodies Research (54 papers) and Immunotherapy and Immune Responses (47 papers). Anne S. De Groot collaborates with scholars based in United States, Switzerland and Mali. Anne S. De Groot's co-authors include William Martin, Leonard Moise, David W. Scott, Julie A. McMurry, Frances Terry, Andrés H. Gutiérrez, Leslie P. Cousens, Rino Rappuoli, Hakima Sbai and Ryan Tassone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Anne S. De Groot

221 papers receiving 6.0k citations

Peers

Countries citing papers authored by Anne S. De Groot

Since Specialization

Citations

This map shows the geographic impact of Anne S. De Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne S. De Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne S. De Groot more than expected).

Fields of papers citing papers by Anne S. De Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne S. De Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne S. De Groot. The network helps show where Anne S. De Groot may publish in the future.

Co-authorship network of co-authors of Anne S. De Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Anne S. De Groot. A scholar is included among the top collaborators of Anne S. De Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne S. De Groot. Anne S. De Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant personalized cancer vaccines: the final frontier? 2024 ·Expert Review of Vaccines ·Guilhem Richard, (unknown), Gary D. Steinberg, William Martin, Anne S. De Groot	8
2	Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics 2023 ·The AAPS Journal ·Kirk Haltaufderhyde, Brian Roberts, (unknown), Frances Terry, (unknown), (unknown), William Martin, Amy S. Rosenberg, Anne S. De Groot	10
3	Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning 2023 ·Nature Biomedical Engineering ·Emily K. Makowski, (unknown), Jennifer M. Zupancic, Jie Huang, Lina Wu, John S. Schardt, Anne S. De Groot, (unknown), William Martin, Peter M. Tessier	21
4	Diversity and evolution of computationally predicted T cell epitopes against human respiratory syncytial virus 2023 ·PLoS Computational Biology ·Jiani Chen, (unknown), Vasanthi Avadhanula, Leonard Moise, Pedro A. Piedra, Anne S. De Groot, Justin Bahl	4
5	H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans 2022 ·Influenza and Other Respiratory Viruses ·(unknown), Leonard Moise, (unknown), Constantinos S. Kyriakis, Andrés H. Gutiérrez, Ted M. Ross, Justin Bahl, Anne S. De Groot	1
6	Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy 2021 ·Expert Review of Vaccines ·Guilhem Richard, Michael F. Princiotta, Dominique Bridon, William Martin, Gary D. Steinberg, Anne S. De Groot	37
7	Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation 2021 ·npj Vaccines ·(unknown), Andrés H. Gutiérrez, (unknown), Frances Terry, Bethany McGonnigal, Andres Μ. Salazar, Michael F. Princiotta, (unknown), Anne S. De Groot, Leonard Moise	29
8	Tregitopes improve murine asthma by promoting highly suppressive and antigen specific Tregs 2020 ·Journal of Allergy and Clinical Immunology ·Marieme Dembele, (unknown), Amir Hossein Massoud, Victoria Zismanov, (unknown), (unknown), Bruce Mazer, Anne S. De Groot	2
9	Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines 2020 ·Expert Review of Vaccines ·Leonard Moise, Ted M. Ross, Daniel F. Hoft, William Martin, Anne S. De Groot	1
10	Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever 2019 ·Infection and Immunity ·Anja Scholzen, Guilhem Richard, Leonard Moise, (unknown), Chantal P. Bleeker‐Rovers, Patrick M. Reeves, Susan Raju Paul, William Martin, Anne S. De Groot, Mark C. Poznansky, Ann E. Sluder, Anja Garritsen	11
11	Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi 2019 ·Human Vaccines & Immunotherapeutics ·(unknown), (unknown), Andrés H. Gutiérrez, Frances Terry, Leonard Moise, William Martin, Anne S. De Groot	18
12	T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response 2018 ·Human Vaccines & Immunotherapeutics ·Leonard Moise, Bethany M. Biron, (unknown), Neşe Kurt Yılmaz, Hyesun Jang, Celia A. Schiffer, Ted M. Ross, William Martin, Anne S. De Groot	9
13	An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice 2017 ·Human Vaccines & Immunotherapeutics ·(unknown), Frances Terry, Leonard Moise, Drew Hannaman, William Martin, Anne S. De Groot, John J. Suschak, Lesley C. Dupuy, Connie S. Schmaljohn	24
14	De-immun ized and F unctional T herapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy 2017 ·Clinical Immunology ·(unknown), (unknown), Marina Etcheverrigaray, Frances Terry, William Martin, Anne S. De Groot	17
15	T‐cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin 2017 ·Influenza and Other Respiratory Viruses ·Andrés H. Gutiérrez, Vicki Rapp-Gabrielson, Frances Terry, Crystal L. Loving, Leonard Moise, William Martin, Anne S. De Groot	15
16	Barriers to Health Insurance Pre- and Post-Affordable Care Act Implementation in Providence, RI. 2015 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Anne S. De Groot	2
17	Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines 2012 ·Human Vaccines & Immunotherapeutics ·(unknown), Eltahir Awad Gasim Khalil, Anne S. De Groot, Ahmed Musa, Andrés H. Gutiérrez, Brima M. Younis, (unknown), A.M. El-Hassan	31
18	New vaccines needed for pathogens infecting animals and humans 2012 ·Human Vaccines & Immunotherapeutics ·Andrés H. Gutiérrez, (unknown), Cyril G. Gay, Mirko Zimic, Anne S. De Groot	11
19	Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis 2011 ·SHILAP Revista de lepidopterología ·Wassim Elyaman, Samia J. Khoury, David W. Scott, Anne S. De Groot	26
20	From Immunome to Vaccine: Epitope Mapping and Vaccine Design Tools 2003 ·Novartis Foundation symposium ·Anne S. De Groot, William Martin	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact